Clinical Trials Directory

Trials / Terminated

TerminatedNCT02343159

Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.

A Multicenter, Open-label Phase IV Study to Evaluate Whether a Medication Event Monitoring System (MEMS®) Can Improve Adherence to Tecfidera® (Delayed-release Dimethyl Fumarate) Treatment in Multiple Sclerosis Patients.

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Biogen · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the study is to determine whether a Medication Event Monitoring System (MEMS®) cap with a liquid crystal display (LCD) reader (a "smart" cap) along with additional patient counseling intervention (Arm 3) can improve adherence to dimethyl fumarate (DMF) treatment in Multiple Sclerosis (MS) patients as compared to a MEMS cap without an LCD reader (a "standard" cap) and no patient counseling intervention (standard of care, Arm 1) at Month 12. The secondary objectives of this study in this study population are: to determine if data display on a smart MEMS cap with an LCD reader (Arm 2) can improve adherence as compared to a standard MEMS cap without an LCD reader (Arm 1) at Month 12; to determine whether the addition of patient counseling intervention based on MEMS data (Arm 3), or data display from a MEMS cap with an LCD reader (Arm 2) can improve adherence compared to standard MEMS cap without an LCD reader (Arm 1) at Month 6; to assess persistence and compliance at Months 6 and 12 for all arms; to assess the association between adherence and patient- reported outcomes (PROs) for all arms including Multiple Sclerosis Impact Scale (MSIS-29), and the Work Productivity and Activity Impairment Questionnaire (WPAI): MS v2.0.

Conditions

Interventions

TypeNameDescription
DRUGdimethyl fumarate120 mg and 240 mg delayed release capsules
DEVICEMedication Event Monitoring System (MEMS)The MEMS automatically compiles drug dosing history data by electronically recording the date and time of each opening of the medication container
BEHAVIORALAdherence counselingA telephone call to discuss adherence and individualized strategies based on data collected via smart device (i.e., LCD reader)

Timeline

Start date
2015-02-28
Primary completion
2016-04-15
Completion
2016-04-15
First posted
2015-01-21
Last updated
2017-05-16
Results posted
2017-05-16

Locations

29 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02343159. Inclusion in this directory is not an endorsement.